Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy

被引:67
作者
Gross, R [1 ]
Bilker, WB
Friedman, HM
Coyne, JC
Strom, BL
机构
[1] Univ Penn, Sch Med, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Ctr Educ & Res Therapeut, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA
关键词
D O I
10.1097/00002030-200209060-00021
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We studied the ability of providers to predict and estimate patient adherence to newly initiated highly active antiretroviral therapy (HAART). Nineteen providers referring 40 patients into an adherence study were surveyed. Widespread inaccuracy was found in providers' adherence predictions and estimates. Therefore, HAART should not be withheld solely on provider predictions of adherence. Providers should not rely on their own assessments when attempting to determine if patients are adhering to therapy.
引用
收藏
页码:1835 / 1837
页数:3
相关论文
共 11 条
[1]   Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population [J].
Bangsberg, DR ;
Hecht, FM ;
Charlebois, ED ;
Zolopa, AR ;
Holodniy, M ;
Sheiner, L ;
Bamberger, JD ;
Chesney, MA ;
Moss, A .
AIDS, 2000, 14 (04) :357-366
[2]   Factors influencing physicians' judgments of adherence and treatment decisions for patients with HIV disease [J].
Bogart, LM ;
Catz, SL ;
Kelly, JA ;
Benotsch, EG .
MEDICAL DECISION MAKING, 2001, 21 (01) :28-36
[3]  
Bogart LM, 2000, J ACQ IMMUN DEF SYND, V23, P396
[4]   Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel [J].
Carpenter, CCJ ;
Cooper, DA ;
Fischl, MA ;
Gatell, JM ;
Gazzard, BG ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schechter, M ;
Schooley, RT ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (03) :381-390
[5]   Effect of adherence to newly initiated antiretroviral therapy on plasma viral load [J].
Gross, R ;
Bilker, WB ;
Friedman, HM ;
Strom, BL .
AIDS, 2001, 15 (16) :2109-2117
[6]   Antiretroviral drug resistance testing in adults with HIV infection -: Implications for clinical management [J].
Hirsch, MS ;
Conway, B ;
D'Aquila, RT ;
Johnson, VA ;
Brun-Vézinet, F ;
Clotet, B ;
Demeter, LM ;
Hammer, SM ;
Jacobsen, DM ;
Kuritzkes, DR ;
Loveday, C ;
Mellors, JW ;
Vella, S ;
Richman, DD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (24) :1984-1991
[7]   Adherence in AIDS clinical trials: A framework for clinical research and clinical care [J].
Ickovics, JR ;
Meisler, AW .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1997, 50 (04) :385-391
[8]   MEASUREMENT OF OBSERVER AGREEMENT FOR CATEGORICAL DATA [J].
LANDIS, JR ;
KOCH, GG .
BIOMETRICS, 1977, 33 (01) :159-174
[9]   Adherence to protease inhibitor therapy and outcomes in patients with HIV infection [J].
Paterson, DL ;
Swindells, S ;
Mohr, J ;
Brester, M ;
Vergis, EN ;
Squier, C ;
Wagener, MM ;
Singh, N .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (01) :21-30
[10]   Should physicians withhold highly active antiretroviral therapies from HIV-AIDS patients who are thought to be poorly adherent to treatment? [J].
Sollitto, S ;
Mehlman, M ;
Youngner, S ;
Lederman, MM .
AIDS, 2001, 15 (02) :153-159